1,2,3-Substituted Triazoles Used as Selective NR2B NMDA Modulators

MA44008AUndetermined Publication Date: 2018-12-19JANSSEN PHARMA NV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA44008
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2016-02-10
Filing Date
2017-02-09
Publication Date
2018-12-19
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.